InvestorsHub Logo
Followers 42
Posts 4839
Boards Moderated 0
Alias Born 04/30/2005

Re: Investor2014 post# 290489

Monday, 12/28/2020 6:12:47 PM

Monday, December 28, 2020 6:12:47 PM

Post# of 458205
Thanks Investor. I assume that Anavex needed time to meet with the FDA (to get specific guidelines for the next trial) before they could request funding from the Shake-It-Up Foundation.

Is that your take as well?

"In August 2020, we announced a financial commitment by Shake It Up Australia Foundation (SIUAF) for Parkinson’s Research to fund up to 50% of the costs of an Australian clinical study to develop ANAVEX®2-73 for the disease modifying treatment of Parkinson’s disease. The financial commitment would be made through private placement purchases of our common stock at 200% of the fair market value on the purchase date and will be contingent upon the completion of certain clinical trial milestones relating to the proposed clinical trial. There was no impact on our consolidated financial statements for the year ended September 30, 2020 as a result of the commitment from SIUAF."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News